Autori del Servizio Sanitario Regionale

Articolo e studi di altri autori

  • Kim AM, Tingen CM, Woodruff TK. Sex bias in trials and treatment must end. Nature. 2010;465(7299):688-689. Articolo completo:10.1038/465688a

  • Check Hayden E. Sex bias blights drug studies. Nature. 2010;464(7287):332-333. Articolo completo:10.1038/464332b

  • Zopf Y, Rabe C, Neubert A, et al. Women encounter ADRs more often than do men. Eur J Clin Pharmacol. 2008;64(10):999-1004. Articolo completo:10.1007/s00228-008-0494-6

  • Ruiz Cantero MT, Angeles Pardo M. European Medicines Agency policies for clinical trials leave women unprotected. J Epidemiol Community Health. 2006;60(11):911-913. Articolo completo:10.1136/jech.2006.048769

  • Geller SE, Adams MG, Carnes M. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials. J Womens Health (Larchmt). 2006;15(10):1123-1131. Articolo completo:10.1089/jwh.2006.15.1123

  • Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352(13):1293-1304. Articolo completo:10.1056/NEJMoa050613

  • Levin RI. The puzzle of aspirin and sex. N Engl J Med. 2005;352(13):1366-1368. Articolo completo:10.1056/NEJMe058051

  • Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15-19. Articolo completo:10.1136/bmj.329.7456.15

  • Montastruc JL, Lapeyre-Mestre M, Bagheri H, Fooladi A. Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France. Fundam Clin Pharmacol. 2002;16(5):343-346. Articolo completo:10.1046/j.1472-8206.2002.00100.x

  • Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-1205. Articolo completo:10.1001/jama.279.15.1200